Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment

Österreich Nachrichten Nachrichten

Six-year follow-up data on survival, benefits for patients with metastatic NSCLC and nivolumab + ipilimumab treatment
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

Research findings from the CheckMate 227 trial will be presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2023 in Singapore, shedding light on the six-year survival and quality of life benefits associated with first-line nivolumab + ipilimumab therapy.

retrieved 9 September 2023 from https://medicalxpress.com/news/2023-09-six-year-follow-up-survival-benefits-patients.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

medical_xpress /  🏆 101. in UK

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Exhaled breath analysis shows promise in detecting malignant pleural mesotheliomaExhaled breath analysis shows promise in detecting malignant pleural mesotheliomaIdentifying and analyzing volatile organic compounds in exhaled breath of patients with malignant pleural mesothelioma showed promise as a screening method for MPM, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.
Weiterlesen »

Color of phlegm can predict outcomes for patients with the lung disease, bronchiectasisColor of phlegm can predict outcomes for patients with the lung disease, bronchiectasisThe color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.
Weiterlesen »

How curiosity sparked pioneering cancer researchHow curiosity sparked pioneering cancer research'I did this research by chance. I was enrolled at the Koch Institute for Integrative Cancer Research at MIT for my postdoctoral work to develop electrical devices with biotechnology. The institute is focused on cancer research and I happened to view other groups' work on cancer cells. I thought, 'This is quite interesting', and wondered if I could extend my work to cancer research,' said Assistant Professor Desmond Loke at the Singapore University of Technology and Design (SUTD).
Weiterlesen »

Scots mum diagnosed with terminal cancer 'just wants more time with family'Scots mum diagnosed with terminal cancer 'just wants more time with family'Sarah McDiarmid has now raised a staggering £22,110 for a charity close to her heart – after initially aiming to raise £1,000.
Weiterlesen »

Renfrewshire schoolboy has to 'grow up quick' after mum's cancer diagnosisRenfrewshire schoolboy has to 'grow up quick' after mum's cancer diagnosisAlfie Colquhoun, nine, has been making chocolate top hats and crispy cakes in an effort to raise money after his mum, Jennifer, was diagnosed with secondary breast cancer.
Weiterlesen »



Render Time: 2025-03-01 23:28:23